Skip to main content
Margaret Shipp, MD, Oncology, Boston, MA, Brigham and Women's Hospital

MargaretAnnShippMD

Oncology • Boston, MA

Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Join to view full profile

Dr. Shipp is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shipp's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1983 - 1986
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1979 - 1982
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1979
  • Southern Methodist University
    Southern Methodist UniversityB.A., English and Biology, 1975

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1984 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Institute of Medicine (IOM) 2014
  • Claire W. and Richard P. Morse Research Award Dana-Farber Cancer Institute, 2011
  • Leloir Prize of International Cooperation in Science, Technology and Innovation Nacional de Relaciones Internacionales, Argentina, 2010
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Targeted Inhibition of PI3Kα/Δ Is Synergistic with BCL-2 Blockade in Genetically Defined Subtypes of DLBCL  
    Anthony Letai, Margaret A Shipp, Blood
  • Publisher Correction: Molecular Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct Pathogenic Mechanisms and Outcomes  
    Thomas M Habermann, Scott J Rodig, Rameen Beroukhim, Jeremiah A Wala, Andrew L Feldman, Todd R Golub, Margaret A Shipp, Nature
  • Mass Cytometry of Hodgkin Lymphoma Reveals a CD4+ Exhausted T-effector and T-regulatory Cell Rich Microenvironment  
    David Wu, Margaret A Shipp, Jonathan R Fromm, Philippe Armand, Scott J Rodig, Blood
  • Join now to see all

Abstracts/Posters

  • Validation of the Genetically-Defined DLBCL Subtypes and Generation of a Parsimonious Probabilistic Classifier
    Margaret A. Shipp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Three-Year Follow-up of Keynote-087: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma
    Margaret A. Shipp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Comparative Genomic Analyses Defines Shared and Unique Features of cHL and PMBL and New Mechanisms of Sensitivity to PD-1 Blockade
    Margaret A. Shipp, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Changing the Taxonomy of Aggressive Lymphoma: Ready to Impact Clinical Management? 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 StudiesClinically Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Integrated Genetic and Topological Analysis Reveals a Hodgkin-like Mechanism of Immune Escape in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • The American Society of Hematology Recognizes Stephen Ansell, M.D. Of Mayo Clinic with the 2021 Ernest Beutler Lecture and Prize
    The American Society of Hematology Recognizes Stephen Ansell, M.D. Of Mayo Clinic with the 2021 Ernest Beutler Lecture and PrizeDecember 13th, 2021
  • Mayo Clinic Research in the News — 7/26/2021
    Mayo Clinic Research in the News — 7/26/2021July 26th, 2021
  • On Second Thought, Lenalidomide Does Improve DLBCL Outcomes
    On Second Thought, Lenalidomide Does Improve DLBCL OutcomesJuly 15th, 2019
  • Join now to see all

Hospital Affiliations

External Links

Dr. Margaret Shipp, Dr. Margaret Shipp, MD, Dr. M Shipp, Dr. Margaret Ann Shipp